Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units) Based on Product
Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units) Based on End user
Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units) Based on Region
Europe
North America
Asia Pacific
Latin America
Middle East & Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Drug-coated Balloons Market Snapshot
Chapter 4. Global Drug-coated Balloons Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2022 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Products:
5.2.1. Drug-Coated Balloons for Peripheral Artery Disease
5.2.2. Drug-Coated Balloons for Coronary Artery Disease
5.2.3. Drug-Coated Balloons for Other Indications
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2022& 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-User:
6.2.1. Hospitals
6.2.2. Cardiac Catherization Labs
6.2.3. Ambulatory Surgical Centers
Chapter 7. Drug-coated Balloons Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By Products, 2022 - 2030
7.1.2. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.1.3. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030
7.2. Europe
7.2.1. Europe Drug-coated Balloons Market revenue (US$ Million) By Products, 2022 - 2030
7.2.2. Europe Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.2.3. Europe Drug-coated Balloons Market revenue (US$ Million) by country, 2022 - 2030
7.3. Asia Pacific
7.3.1. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) By Products, 2022 - 2030
7.3.2. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.3.3. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) by country, 2022 - 2030
7.4. Latin America
7.4.1. Latin America Drug-coated Balloons Market revenue (US$ Million) By Products, (US$ Million)
7.4.2. Latin America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.4.3. Latin America Drug-coated Balloons Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
7.5. Middle East & Africa
7.5.1. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) By Products, (US$ Million)
7.5.2. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.5.3. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Medtronic
8.2.2. BD
8.2.3. Koninklijke Philips
8.2.4. Braun Melsungen
8.2.5. BIOTRONIK
8.2.6. Boston Scientific
8.2.7. Opto Circuits (India)
8.2.8. Acotec Scientific
8.2.9. AR Baltic Medical
8.2.10. Acrostak
8.2.11. Biosensors International Group
8.2.12. Cardionovum
8.2.13. Concept Medical
8.2.14. ENDOCOR
8.2.15. Hexacath
8.2.16. iVascular SLU
8.2.17. M.A. Med Alliance
8.2.18. Minvasys
8.2.19. Orchestra BioMed
8.2.20. QT Vascular
8.2.21. RD Global-Invamed
8.2.22. Surmodics
8.2.23. Terumo
8.2.24. Wellinq
8.2.25. Other prominent players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.